“The National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements (CDE]): What They Are, Ways to Use Them, and Gaps, Mini-Symposium”, in American Academy for Cerebral Palsy and Developmental Medicine 77th Annual Meeting, Chicago, IL, 2023.
, “Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women”, J Infect Dis, vol. 227, no. 4, pp. 522-527, 2023.
, “Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.”, JAMA Intern Med, 2023.
, “Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.”, J Antimicrob Chemother, vol. 78, no. 6, pp. 1460-1470, 2023.
, “A Randomized, Controlled Phase 1b Trial of the Sm-TSP-2 Vaccine for Intestinal Schistosomiasis in Healthy Brazilian Adults Living in an Endemic Area”, PLoS Negl Trop Dis, vol. 17, no. 3, p. e0011236, 2023.
, “Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.”, Clin Infect Dis, 2023.
, “Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: a Randomized, Controlled Phase 1 Study.”, J Infect Dis, 2023.
, “Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial.”, Vaccine, vol. 41, no. 16, pp. 2716-2722, 2023.
, “SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes”, Am J Ophthalmol, vol. 248, pp. 157-163, 2023.
, “Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.”, JAMA, vol. 330, no. 9, pp. 843-853, 2023.
, “Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods.”, Addict Sci Clin Pract, vol. 18, no. 1, p. 70, 2023.
, “Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study”, Contemp Clin Trials, vol. 128, p. 107148, 2023.
, , “Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions.”, Infect Dis Ther, vol. 11, no. 2, pp. 841-852, 2022.
, “The Antibody Landscapes Following AS03 and MF59 Adjuvanted H5N1 Vaccination”, NPJ Vaccines, vol. 7, no. 1, p. 103, 2022.
, “Baricitinib versus Dexamethasone for Adults Hospitalised with COVID-19 (ACTT-4): a Randomised, Double-blind, Double Placebo-controlled Trial”, Lancet Respir Med, vol. 10, no. 9, pp. 888-899, 2022.
, “Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants with Hemiretinal Vein Occlusion Compared With Participants with Central Retinal Vein Occlusion (SCORE2) Report 18”, JAMA Ophthalmol, vol. 140, no. 5, pp. 458-464, 2022.
, “Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods”, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
, “Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups”, J Clin Oncol, vol. 40, no. 13, pp. 1500-1505, 2022.
, “Cumulative Lactation and Clinical Metabolic Outcomes at Mid-Life among Women with a History of Gestational Diabetes”, Nutrients, vol. 14, no. 3, 2022.
, “Development of a Generic Physiologically-Based Pharmacokinetic Model for Lactation and Prediction of Maternal and Infant Exposure to Ondansetron via Breast Milk”, Clin Pharmacol Ther, vol. 5, 2022.
, “Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum”, J Infect Dis, vol. 226, no. 10, pp. 1771-1780, 2022.
, “EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil”, Trials, vol. 23, no. 1, p. 185, 2022.
, “Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence.”, J Mol Diagn, vol. 24, no. 3, pp. 219-223, 2022.
, “First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E”, Antimicrob Agents Chemother, vol. 66, no. 4, p. e0173221, 2022.
,